However, germline and somatic changes in FANCC and FANCG may have comparatively low penetrance for pancreatic cancer [55], which is supported by studies investigating germline mutations of upstream FA pathway genes in sporadic, yet FA-typical tumors among the general population [59]. This evidence concerns the gene FANCC and familial pancreatic carcinoma.